EUVIMEDEUVIMED entdecken
Randomisierte kontrollierte StudieOpen Access · CC BY 4.0

Platelet-rich fibrin ensures hemostasis after single-tooth removal under factor Xa inhibitors — a clinical prospective randomized split-mouth study

Solomiya Kyyak, Ali Jari, Diana Heimes, Julia Heider, Peer W Kämmerer

Clinical Oral Investigations · 2023

DOI: 10.1007/s00784-023-05317-3 ↗

Kurz gefasst

Randomisierte kontrollierte Studie in der Zeitschrift Clinical Oral Investigations, 2023. Verfasst von Solomiya Kyyak und 4 weiteren Autor:innen. Beteiligte Einrichtung: Department of Oral and Maxillofacial Surgery, University Medical Center Mainz, Augustusplatz 2, 55131, Mainz, Germany. solomiya.kyyak@unimedizin-main…. Hauptthemen laut MEDLINE: Platelet-Rich Fibrin, Hemostatics. Die Arbeit wurde bisher 11-mal zitiert (Crossref) und nennt 57 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Universitätsmedizin der Johannes Gutenberg-Universität Mainz.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Objectives

In this prospective, double-blinded, randomized split-mouth study, the local hemostatic effect of platelet-rich fibrin (PRF) inserted into the extraction socket in patients taking factor Xa (FXa) inhibitors (apixaban, rivaroxaban, edoxaban) was compared to a hemostatic gelatine sponge (GS) as the “therapeutic gold standard” without withdrawal of oral anticoagulant therapy. Materials and methods Single-tooth extraction was conducted under local anesthesia in n = 21 patients using a split-mouth design (42 teeth). Using a double-blind approach, the extraction socket on one side of the jaw was filled with PRF and on the other with a GS. Bleeding was assessed immediately after surgery, in 30 min, 1 h, 1.5 h, and on follow-up appointments in 24 h and on the 7th day.

Results

In 67% of cases, mild postoperative oozing could be stopped 30–90 min after tooth extraction via gauze pressure without any delayed bleeding. Concerning bleeding events, there was no difference among the PRF and GS groups and no significant difference among rivaroxaban, apixaban, and edoxaban (all p > 0.15).

Conclusion

PRF and GS are reliable hemostatic methods in postextraction sockets of patients taking FXa inhibitors. Clinical relevance Consequently, there is no need to discontinue FXa inhibitors because of a single-tooth removal, eliminating the risk of thrombus formation.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Platelet-Rich FibrinHemostaticsHumansFactor Xa InhibitorsRivaroxabanProspective StudiesTooth ExtractionMouthHemostasisPyridinesThiazoles

Stichwörter der Autor:innen

Factor Xa inhibitorsHemostatic effectHemostatic spongeIntra- and postoperative bleedingPlatelet-rich fibrinTooth extraction

Substanzen

Factor Xa InhibitorsRivaroxabanHemostaticsedoxabanPyridinesThiazoles

Autor:innen und Institutionen

  • Department of Oral and Maxillofacial Surgery, University Medical Center Mainz, Augustusplatz 2, 55131, Mainz, Germany. solomiya.kyyak@unimedizin-mainz.de.
  • Department of Oral and Maxillofacial Surgery, University Medical Center Mainz, Augustusplatz 2, 55131, Mainz, Germany.

Förderung

  • Universitätsmedizin der Johannes Gutenberg-Universität Mainz

Zitieren

APA

Kyyak, S., Jari, A., Heimes, D., Heider, J., & Kämmerer, P. W. (2023). Platelet-rich fibrin ensures hemostasis after single-tooth removal under factor Xa inhibitors — a clinical prospective randomized split-mouth study. Clinical Oral Investigations. https://doi.org/10.1007/s00784-023-05317-3

Vancouver

Kyyak S, Jari A, Heimes D, Heider J, Kämmerer PW. Platelet-rich fibrin ensures hemostasis after single-tooth removal under factor Xa inhibitors — a clinical prospective randomized split-mouth study. Clinical Oral Investigations. 2023. doi:10.1007/s00784-023-05317-3

BibTeX
@article{Kyyak2023,
  author = {Kyyak, Solomiya and Jari, Ali and Heimes, Diana and Heider, Julia and Kämmerer, Peer W},
  title = {Platelet-rich fibrin ensures hemostasis after single-tooth removal under factor Xa inhibitors — a clinical prospective randomized split-mouth study},
  journal = {Clinical Oral Investigations},
  year = {2023},
  doi = {10.1007/s00784-023-05317-3}
}
Kostenlos starten →